ArticleCureus2026

Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus?

Regina Medeiros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.